ํด๋ก๋์ ํ
ํด๋ก๋์ ํ์ ๊ฐ๋ ฅํ๊ณ ์ง์ ์๊ฐ์ด ๊ธด **๋ฒค์กฐ๋์์ ํ๊ณ** ์ฝ๋ฌผ๋ก, ์์ํ์์๋ ์ฃผ๋ก ๋ณด์กฐ ํญ๊ฒฝ๋ จ์ ๋ฐ ํญ๋ถ์์ ๋ก ์ฌ์ฉ๋ฉ๋๋ค. > **์์ ์์ :** ๊ฐ์์๋ ํญ๊ฒฝ๋ จ ํจ๊ณผ์ ๋ํ ๋ด์ฑ์ด ๋น ๋ฅด๊ฒ(๋ณดํต 1~4์ฃผ ์ด๋ด) ๋ฐ์ํ๊ธฐ ๋๋ฌธ์ ์ฅ๊ธฐ ์ ์ง ํญ๊ฒฝ๋ จ์ ๋ก์์ ์ ์ฉ์ฑ์ด ๋งค์ฐ ์ ํ์ ์ ๋๋ค. ์ด๋ ์์ฉ์ฒด ํํฅ ์กฐ์ ๋ฐ ์ฝ๋ํ์ ๋ณํ ๋๋ฌธ์ ๋๋ค. ๋ฐ๋ผ์ ๋จ๊ธฐ ํ์ค ์๋ฒ์ด๋ ๊ตฐ๋ฐ ๋ฐ์ ๊ด๋ฆฌ์ ํจ์ฌ ๋ ์ ํฉํฉ๋๋ค. - ๊ณ ์์ด์ ๊ฒฝ์ฐ ๋์ ์ฆ์ด๋ ๋ถ์์ฆ์ ์ฅ๊ธฐ ๋ณด์กฐ ์น๋ฃ์ ์ฌ์ฉํ ์ ์์ต๋๋ค. ๊ณ ์์ด์์ ๊ฒฝ๊ตฌ์ฉ ๋ฒค์กฐ๋์์ ํ(๊ฐ์ฅ ๋ํ์ ์ผ๋ก ๋์์ ํ)์ ํน์ด์ฒด์ง์ฑ ๊ธ์ฑ ๊ฐ๊ดด์ฌ๋ฅผ ์ ๋ฐํ ์ํ์ด ์๋ ๊ฒ์ผ๋ก ์๋ ค์ ธ ์์ผ๋, ํด๋ก๋์ ํ์ ๊ทธ ๊ฐ๋ฅ์ฑ์ด ๋ ๋ฎ์ ๊ฒ์ผ๋ก ๊ฐ์ฃผ๋ฉ๋๋ค. ํ์ง๋ง ์ฌ์ ํ ๋ชจ๋ํฐ๋ง์ด ํ์ํฉ๋๋ค. - ํด๋ก๋์ ํ์ ์ค๋จ์ฉ ๋ฐ ์์กด์ฑ ์ํ์ผ๋ก ์ธํด **์ 4๊ตฐ(C-IV) ํฅ์ ์ ์ฑ์์ฝํ**์ผ๋ก ๋ถ๋ฅ๋ฉ๋๋ค.
์์ฉ ๊ธฐ์ : Clonazepam acts as a positive allosteric modulator at the **GABA-A receptor** complex in the central nervous system. - It binds to specific benzodiazepine receptors (located primarily in the limbic, thalamic, and hypothalamic regions) โ enhances the affinity of the receptor for the inhibitory neurotransmitter **gamma-aminobutyric acid (GABA)**. - This increases the frequency of chloride channel opening โ influx of chloride ions โ cellular hyperpolarization โ decreased neuronal excitability. - Additional postulated mechanisms include antagonism of serotonin and diminished release or turnover of acetylcholine in the CNS.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Anxiolytic ยท 0.05-0.25 mg/kg PO q12-24h ยท PO ยท q12-24h
- Anxiolytic ยท 0.02-0.2 mg/kg PO once to two times a day ยท PO ยท q12-24h
- Anxiolytic ยท 0.1-0.2 mg/kg PO as needed or up to two times a day ยท PO ยท PRN or q12h
- Adjunctive medication in the treatment of seizures ยท Starting dose is 0.5 mg (total dose) PO q12-24h ยท PO ยท q12-24h
- Adjunctive medication in the treatment of seizures ยท 1/8th to 1/4 of a 0.5 mg tablet PO two to three times daily ยท PO ยท q8-12h ยท Anecdotally more effective for maintenance and to decrease cluster seizures; acute hepatic necrosis possible
- Anxiolytic / Hyperaesthesia / Epilepsy ยท 0.5 mg/cat ยท PO ยท q12-24h ยท Suggested starting dose but there is a wide range of recommendations.
- Adjunctive medication in the treatment of seizures ยท 1-2 mg/kg PO q12h ยท PO ยท q12h
- Adjunctive medication in the treatment of seizures ยท 0.5 mg/kg PO two to three times a day ยท PO ยท q8-12h ยท May need to lower phenobarbital dose by 10-20%
- Anxiolytic ยท 0.05-0.25 mg/kg PO q12-24h ยท PO ยท q12-24h
- Anxiolytic ยท 0.1-1 mg/kg PO two to three times a day ยท PO ยท q8-12h
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Hypersensitivity to clonazepam or other benzodiazepines
- Significant liver disease or dysfunction
- Acute narrow-angle glaucoma
- Myasthenia gravis (may exacerbate weakness)
- Marked CNS depression
- Respiratory depression
- Severe muscle weakness
- Hepatic impairment (may worsen hepatic encephalopathy)
- Acute narrow angle glaucoma
์ด์๋ฐ์
- Sedation and lethargy
- Ataxia (incoordination)
- Paradoxical excitement, hyperactivity, or vocalization
- Increased salivation
- Gastrointestinal upset (vomiting, diarrhea, constipation)
- Dogs: Rapid tolerance to anticonvulsant effects
- Cats: Polyphagia, potential for acute hepatic necrosis (rare)
- Sedation
- Respiratory suppression (at higher doses)
- Ataxia
- Acute hepatic necrosis (idiosyncratic in cats)
- Tolerance development
์ฝ๋ฌผ ์ํธ์์ฉ
- Azole Antifungals (itraconazole, ketoconazole) ยท May increase clonazepam levels by inhibiting its metabolism.
- Cimetidine ยท May decrease the metabolism of benzodiazepines, increasing their effects.
- CNS Depressants (barbiturates, narcotics, anesthetics) ยท Additive CNS depression; may cause profound sedation or respiratory depression.
- Erythromycin ยท May decrease the metabolism of benzodiazepines.
- Phenobarbital ยท May decrease clonazepam concentrations via hepatic enzyme induction. ยท moderate
- Phenytoin ยท May decrease clonazepam concentrations. ยท moderate
- Propantheline ยท May decrease clonazepam concentrations.
- Rifampin ยท May induce hepatic microsomal enzymes and decrease the pharmacologic effects of benzodiazepines.
- Antifungal imidazoles (e.g., Ketoconazole, Itraconazole) ยท Inhibition of CYP450 enzymes may decrease clonazepam clearance, increasing its plasma levels and risk of toxicity. ยท moderate
- Other CNS Depressants ยท Additive sedation and respiratory depression. ยท major
๋ชจ๋ํฐ๋ง
- Clinical efficacy (seizure frequency, anxiety levels)
- Adverse effects (sedation, ataxia, paradoxical excitement)
- Therapeutic blood levels (reported target: 0.015-0.07 mcg/mL)
- Cats: Baseline and periodic liver function tests
- Degree of sedation and ataxia
- Respiratory rate and effort
- Hepatic function panel (especially in cats)
- Clinical response (seizure frequency, muscle tone, or behavioral changes)
๊ณผ์ฉ๋
Overdoses commonly cause profound **sedation, depression, and ataxia**. - **Paradoxical Reactions:** Some animals may exhibit paradoxical signs such as hyperactivity, disorientation, agitation, and vocalization. Paradoxical excitation can be treated with a mild sedative, such as diphenhydramine. - **Management:** Emesis is generally NOT indicated due to the risk of rapid CNS depression and aspiration. Mild to moderate overdoses can often be monitored at home if the animal is rousable and not showing paradoxical signs. Keep the animal confined and minimize stimulation. - **Severe Toxicity:** Massive overdoses can lead to respiratory depression or hypotension. **Flumazenil** (a specific benzodiazepine antagonist) can be used to reverse severe respiratory or CNS depression. Because flumazenil has a short half-life, multiple doses may be required.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.